Which has the lower trailing P/E, GILD or NVO?

NVO has the lower trailing P/E: GILD trades at 17.74 and NVO at 11.01. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, GILD or NVO?

Over the past five years, NVO grew revenue faster — GILD at a 3.07% CAGR versus NVO at 20.73%.

Does GILD or NVO pay a bigger dividend?

GILD yields 2.47% and NVO yields 3.83% based on trailing dividends and the latest price.

Is GILD or NVO more profitable?

NVO runs the higher net margin — GILD at 30.99% versus NVO at 37.14%.

How have GILD and NVO total returns compared?

Over the past 10 years, GILD delivered 8.85% and NVO delivered 7.59% annualized total return. Past performance doesn't predict future results.

Gilead Sciences, Inc. (GILD) vs Novo Nordisk A/S (NVO)

A side-by-side comparison of Gilead Sciences, Inc. and Novo Nordisk A/S across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 1, 2026. Differences are shown without an overall score or investment verdict.

GILD

Gilead Sciences, Inc.

$161.66B

$130.21HealthcareAt close: Jul 31, 2026, 4:00 PM ET

NVO

Novo Nordisk A/S

$209.19B

$47.08HealthcareDelayed quote: Jul 31, 2026, 3:59 PM EDT

Total return — GILD vs NVO

growth of $100 · dividends reinvested · last 30y

GILD +32287.6%NVO +10806.6%GILD compounded faster

GILD NVO

GILD vs NVO: by the numbers

•NVO is the larger company ($209.19B vs $161.66B market cap).
•NVO trades at the lower trailing earnings multiple (11.01 vs 17.74 P/E), one valuation lens rather than an overall verdict.
•NVO converts more revenue to profit (37.14% vs 30.99% net margin).
•NVO grew revenue faster over the past five years (20.73% vs 3.07% CAGR).
•NVO pays the higher dividend yield (3.83% vs 2.47%).

Metrics side by side

Valuation

Metric	GILD	NVO
P/E ratio	17.74	11.01
P/S ratio	5.49	4.09
P/B ratio	6.94	6.69
PEG ratio	0.01	8.16
EV / EBITDA	12.59	8.62
FCF yield	6.27%	2.31%

Profitability

Metric	GILD	NVO
Gross margin	79.35%	81.83%
Operating margin	38.26%	45.21%
Net margin	30.99%	37.14%
ROE	39.19%	60.74%
ROIC	21.53%	29.53%

Dividends

Metric	GILD	NVO
Dividend yield	2.47%	3.83%
Payout ratio	47.08%	49.80%

Growth (annualized)

Metric	GILD	NVO
Revenue CAGR (5Y)	3.07%	20.73%
EPS CAGR (5Y)	133.83%	19.59%
FCF CAGR (5Y)	3.30%	-5.86%
Total return CAGR (5Y)	17.98%	2.46%

Frequently asked

Which has the lower trailing P/E, GILD or NVO?: NVO has the lower trailing P/E: GILD trades at 17.74 and NVO at 11.01. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, GILD or NVO?: Over the past five years, NVO grew revenue faster — GILD at a 3.07% CAGR versus NVO at 20.73%.
Does GILD or NVO pay a bigger dividend?: GILD yields 2.47% and NVO yields 3.83% based on trailing dividends and the latest price.
Is GILD or NVO more profitable?: NVO runs the higher net margin — GILD at 30.99% versus NVO at 37.14%.
How have GILD and NVO total returns compared?: Over the past 10 years, GILD delivered 8.85% and NVO delivered 7.59% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GILD analysis Full NVO analysis Interactive comparison tool

Dig into the metrics

Gilead Sciences P/E ratio Novo Nordisk A/S P/E ratio Gilead Sciences dividend yield Novo Nordisk A/S dividend yield Gilead Sciences ROE Novo Nordisk A/S ROE Gilead Sciences operating margin Novo Nordisk A/S operating margin Gilead Sciences revenue growth Novo Nordisk A/S revenue growth Gilead Sciences free cash flow Novo Nordisk A/S free cash flow

Gilead Sciences & Novo Nordisk A/S appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 1, 2026.